First Choice Neurology Press Releases

First Choice Neurology invites the community to join Dr. Jeff Gelblum, one of the nation's leading neurology specialists, for an exclusive Facebook LIVE event on Friday, February 20, at 12:30 PM ET.

The American Epilepsy Society's (AES) Annual Meeting, taking place from December 5 to 9 in Atlanta, is the world's largest gathering for professionals dedicated to the science and clinical care of epilepsy.

First Choice Neurology (FCN) supports the Child Neurology Society (CNS) through exhibiting at the Annual Meeting, October 8–11, 2025, at the Charlotte Convention Center in Charlotte, North Carolina.

The FDA cleared Fujirebio's Lumipulse Plasma Ratio blood test for the early detection of amyloid plaques associated with Alzheimer's disease (AD). Lumipulse is the first in-vitro diagnostic (IVD) test used in the diagnosis of AD.

First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology.

Neurologists working in a hospital-integrated setting experience an average income reduction of $9,652

Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.

Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.

First Choice Neurology, the largest neurology group in the United States, is set to make medical history next week as Dr. Jennifer Buczyner and Dr.